首页> 美国卫生研究院文献>Springer Open Choice >Ranibizumab Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

【2h】

Ranibizumab Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

机译：雷尼单抗韦替泊芬光动力疗法或近视脉络膜新生血管治疗的观察：在英国的成本效益。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeThe aim of this study was to evaluate the cost effectiveness of ranibizumab compared with verteporfin photodynamic therapy (vPDT) or no treatment (observation) in patients with visual impairment due to myopic choroidal neovascularization (CNV).

机译：目的本研究的目的是评估雷尼单抗与韦替泊芬光动力疗法（vPDT）或不治疗（观察）相比因近视脉络膜新生血管（CNV）导致视力障碍的成本效益。

著录项

期刊名称 Springer Open Choice
作者
Lindsay Claxton; Bill Malcolm; Matthew Taylor; Jennifer Haig; Claudia Leteneux;
展开▼
作者单位

展开▼
年(卷),期 -1(31),11
年度 -1
页码 837–848
总页数 12
原文格式 PDF
正文语种
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Ranibizumab, verteporfin photodynamic therapy or observation for the treatment of myopic choroidal neovascularization: cost effectiveness in the UK. [J] . Lindsay Claxton, Bill Malcolm, Matthew Taylor, Drugs and aging . 2014,第11期

机译：雷尼单抗，韦替泊芬光动力疗法或近视脉络膜新生血管治疗的观察：在英国的成本效益。
2. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION BRILLIANCE, a 12-Month, Randomized, Double-Masked Study [J] . Chen Youxin, Sharma Tarun, Li Xiaorong, Retina . 2019,第10期

机译：Ranibizumab与Verteporfin光动力学治疗在亚洲近视脉络膜新生血管中的亮度，一个12个月，随机，双屏蔽的研究
3. Ranibizumab versus verteporfin photodynamic therapy for myopic choroidal neovascularization: Results from RADIANCE [J] . Steinle Nathan, Ghanekar Avanti, Quezada-Ruiz Carlos Investigative ophthalmology & visual science . 2017,第8期

机译：Ranibizumab与近视脉络膜新生血管化的Verteporfin光学动力学治疗：辐射结果
4. Therapeutic response of experimental choroidal neovascularization in mice with photodynamic/photothermal therapy using ICG loaded gold nanorods as a photosensitizer [C] . Rupesh Singh, Julia C. Batoki, Bela Anand-Apte International Photodynamic Association World Congress . 2019

机译：用ICG负载金纳米杆作为光敏剂对小鼠实验脉络膜新生血管形成的疗效
5. A model for choroidal neovascularization (CNV) and gene therapy for age-related macular degeneration (AMD). [D] . Wang, Fei. 2001

机译：脉络膜新生血管（CNV）和年龄相关性黄斑变性（AMD）基因治疗的模型。
6. RANIBIZUMAB VERSUS VERTEPORFIN PHOTODYNAMIC THERAPY IN ASIAN PATIENTS WITH MYOPIC CHOROIDAL NEOVASCULARIZATION [O] . Youxin Chen, Tarun Sharma, Xiaorong Li, -1

机译：RANIBIZUMAB VERSUS VERTEPORFIN在亚洲患者中发生肌性脉络膜新生血管的光动力疗法
7. Ranibizumab, Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK [O] . 2014

机译：雷尼单抗，韦替泊芬光动力疗法或近视脉络膜新生血管治疗的观察：在英国的成本效益。

Ranibizumab Verteporfin Photodynamic Therapy or Observation for the Treatment of Myopic Choroidal Neovascularization: Cost Effectiveness in the UK

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅